Old Web
English
Sign In
Acemap
>
authorDetail
>
H.-J. Lueck
H.-J. Lueck
Internal medicine
Medicine
Pathology
Oncology
Metastatic breast cancer
5
Papers
17
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
00096 PRE-OPERATIVE SELECTION CRITERIA FOR OPERABILITY IN RECURRENT OVARIAN CANCER (DESKTOP-OVAR)
2005
A. du Bois
M. Hahmann
W. Schroeder
C. Muenstedt
Barbara Schmalfeldt
Gunter Emons
J. Pfisterer
Kerstin Wollschlaeger
H. G. Meerpohl
G.-P. Breitbach
Berno Tanner
Jalid Sehouli
V. Heilmann
H.-J. Lueck
Walther Kuhn
P Wimberger
O. Ortmann
P. Harter
Show All
Source
Cite
Save
Citations (0)
Anthracycline and trastuzumab in breast cancer treatment.
2004
Oncology
Michael Untch
I. Himsl
Steffen Kahlert
H.-J. Lueck
H. Eidtmann
Andreas du Bois
H. G. Meerpohl
Christoph Thomssen
Nadia Harbeck
C Jackisch
Rolf Kreienberg
Gunter Emons
Diethelm Wallwiener
W. Wiese
G. Schaller
Walther Kuhn
M. Muscholl
M. Pauschinger
B. Langer
Show All
Source
Cite
Save
Citations (13)
NT-pro-BNP and CA 125 as potential markers of mortality during long-term immunetherapy with trastuzumab in HER-2-positive metastatic breast cancer
2004
Journal of Clinical Oncology
D. Rossner
Karsten Knobloch
R Lichtinghagen
A. Lichtenberg
H. Kuehnle
H.-J. Lueck
Show All
Source
Cite
Save
Citations (0)
Cardiac safety of herceptin(R) in combination with epirubicin plus cyclophosphamide: interim results of a phase II study in patients with metastatic breast cancer
2001
European Journal of Cancer
Michael Untch
G. Schaller
Fritz Jaenicke
W. Jonat
H.-J. Lueck
Show All
Source
Cite
Save
Citations (4)
Topotecan: A “compassionate use” study in patients with advanced epithelial ovarian cancer refractory to other therapies
1997
European Journal of Cancer
T. Bauknecht
H.-J. Lueck
H. Calvert
Rolf Kreienberg
R. Pastovic
Show All
Source
Cite
Save
Citations (0)
1